Advertisement
Advertisement
BCTX
Briacell Therapeutics Corp. Common Shares
4.04
USDSponsored
-0.06
-1.37%
Mar 25, 15:59 UTC -4
Closed
After-Market
4.12
+0.07
+1.76%
BCTX Earnings Reports
Positive Surprise Ratio
BCTX beat 8 of 16 last estimates.
50%
Next Report
Date of Next Report
Jun 15, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$2.76
Implied change from Q2 26 (Revenue/ EPS)
--
/+6.98%
Implied change from Q3 25 (Revenue/ EPS)
--
/-83.16%
Briacell Therapeutics Corp. Common Shares earnings per share and revenue
On Mar 10, 2026, BCTX reported earnings of -2.58 USD per share (EPS) for Q2 26, beating the estimate of -4.88 USD, resulting in a 47.22% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +13.91% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 2 analysts forecast an EPS of -2.76 USD, with revenue projected to reach -- USD, implying an increase of 6.98% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
BioCardia, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.06
Surprise
+65.40%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
FAQ
What were Briacell Therapeutics Corp. Common Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Briacell Therapeutics Corp. Common Shares reported EPS of -$2.58, beating estimates by 47.22%, and revenue of $0.00, 0% as expectations.
How did the market react to Briacell Therapeutics Corp. Common Shares's Q2 2026 earnings?
The stock price moved up 13.91%, changed from $3.81 before the earnings release to $4.34 the day after.
When is Briacell Therapeutics Corp. Common Shares expected to report next?
The next earning report is scheduled for Jun 15, 2026.
What are the forecasts for Briacell Therapeutics Corp. Common Shares's next earnings report?
Based on 2
analysts, Briacell Therapeutics Corp. Common Shares is expected to report EPS of -$2.76 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement